AFJK (Aimei Health Technology Co., Ltd Ordinary Share) Stock Analysis - SEC Filings

Aimei Health Technology Co., Ltd Ordinary Share (AFJK) is a publicly traded Financial Services sector company. As of May 21, 2026, AFJK trades at $40.77 with a market cap of $131.72M and a P/E ratio of 0.00. AFJK moved +13.03% today. Year to date, AFJK is -4.17%; over the trailing twelve months it is +296.33%. Its 52-week range spans $6.75 to $130.37. Rallies surfaces AFJK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find AFJK SEC filings?

Rallies organizes AFJK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

AFJK Key Metrics

Key financial metrics for AFJK
MetricValue
Price$40.77
Market Cap$131.72M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$130.37
52-Week Low$6.75
Volume10.26K
Avg Volume0
Revenue (TTM)$0
Net Income$1.06M
Gross Margin0.00%

Latest AFJK News

Recent AFJK Insider Trades

  • MIZUHO SECURITIES USA LLC sold 150.00K (~$1.63M) on Feb 11, 2025.
  • Aimei Investment Ltd bought 332.00K (~$3.32M) on Dec 1, 2023.

AFJK Analyst Consensus

AFJK analyst coverage data. Average price target: $0.00.

Common questions about AFJK

Where can I find AFJK SEC filings?
Rallies organizes AFJK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show AFJK 10-K and 10-Q filings?
Rallies organizes AFJK SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is AFJK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AFJK. It does not provide personalized investment advice.
AFJK

AFJK